<SEC-HEADER>0000899243-22-021802.hdr.sgml : 20220610
<ACCEPTANCE-DATETIME>20220610073014
<ACCESSION-NUMBER>0000899243-22-021802
<TYPE>4
<PUBLIC-DOCUMENT-COUNT>1
<PERIOD>20220608
<FILING-DATE>20220610
<DATE-OF-FILING-DATE-CHANGE>20220610
<REPORTING-OWNER>
<OWNER-DATA>
<CONFORMED-NAME>Harwin Peter Evan
<CIK>0001663607
</OWNER-DATA>
<FILING-VALUES>
<FORM-TYPE>4
<ACT>34
<FILE-NUMBER>001-36483
<FILM-NUMBER>221007633
</FILING-VALUES>
<MAIL-ADDRESS>
<STREET1>2001 MARKET STREET
<STREET2>SUITE 2500
<CITY>PHILADELPHIA
<STATE>PA
<ZIP>19103
</MAIL-ADDRESS>
</REPORTING-OWNER>
<ISSUER>
<COMPANY-DATA>
<CONFORMED-NAME>Viridian Therapeutics, Inc.\DE
<CIK>0001590750
<ASSIGNED-SIC>8071
<IRS-NUMBER>471187261
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<BUSINESS-ADDRESS>
<STREET1>203 CRESCENT STREET
<STREET2>BLDG. 17, SUITE 102B
<CITY>WALTHAM
<STATE>MA
<ZIP>02453
<PHONE>617.272.4600
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>203 CRESCENT STREET
<STREET2>BLDG. 17, SUITE 102B
<CITY>WALTHAM
<STATE>MA
<ZIP>02453
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>MIRAGEN THERAPEUTICS, INC.
<DATE-CHANGED>20170213
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>MIRAGEN THERAPEUTICS, INC.
<DATE-CHANGED>20170213
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>SIGNAL GENETICS, INC.
<DATE-CHANGED>20140710
</FORMER-COMPANY>
</ISSUER>
</SEC-HEADER>
